Incomplete healing of bone defects in the craniofacial skeleton is common. Osteogenic proteins, including bone morphogenetic protein 2 and 4 (BMP2, -4), promote healing in bone defects, but the proteins' short half-lives and rapid clearance by the bloodstream limit their utility. The main goal of our initial R01 project was the development of tissue engineering approaches, based on muscle-derived stem cells (MDSCs), to efficiently deliver osteogenic proteins and improve craniofacial bone healing. We would like to thank NIDCR for their support during the initial funding period. We met and exceeded all the key objectives in the original R01 application, and our results formed the basis for 24 papers and 52 abstracts. We demonstrated that MDSCs genetically engineered to express BMP2 and BMP4 differentiate toward an osteogenic lineage and can improve bone healing in calvarial and long bone defects. We also found that concomitant expression of vascular endothelial growth factor (VEGF) improves the bone healing observed after implantation of BMP2-and BMP4-expressing MDSCs. This DE013420 competitive renewal application outlines experiments designed to extend our initial findings and facilitate the development of clinical applications of MDSCs to improve bone healing. First, we will examine the effect of the sex and age of donor mice on the number and the osteogenic potential of MDSCs. We will then determine if muscle biopsy size and source, time of culturing, hormonal stimulation, or ex vivo cyclic mechanical strain influence the number or osteogenic potential of MDSCs and might enable us to counterbalance sex-related differences exhibited by MDSCs. This research is integral to the clinical applicability of MDSCs for autologous bone tissue engineering applications, which will necessitate the isolation of highly osteogenic cells from patients of different sexes and ages. Next/we will investigate ways to optimize bone formation and healing by using MDSC-based tissue engineering techniques, including genetic manipulation and injectable scaffolds. Finally, we will use the results from the first 2 aims to isolate and characterize the human equivalents of the mouse MDSCs with the highest osteogenic potential and optimize their use for bone regeneration and repair. The proposed study will provide important information regarding the basic biology of MDSCs and their use for bone healing and should foster the development of clinical treatments for osseous deficiencies. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE013420-07
Application #
7234129
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Lumelsky, Nadya L
Project Start
2006-07-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
7
Fiscal Year
2007
Total Cost
$338,782
Indirect Cost
Name
Children's Hosp Pittsburgh/Upmc Health Sys
Department
Type
DUNS #
044304145
City
Pittsburgh
State
PA
Country
United States
Zip Code
15224
Gao, Xueqin; Lu, Aiping; Tang, Ying et al. (2018) Influences of donor and host age on human muscle-derived stem cell-mediated bone regeneration. Stem Cell Res Ther 9:316
Gao, Xueqin; Usas, Arvydas; Lu, Aiping et al. (2016) Cyclooxygenase-2 deficiency impairs muscle-derived stem cell-mediated bone regeneration via cellular autonomous and non-autonomous mechanisms. Hum Mol Genet 25:3216-3231
Tian, Ke; Qi, Min; Wang, Limin et al. (2015) Two-stage therapeutic utility of ectopically formed bone tissue in skeletal muscle induced by adeno-associated virus containing bone morphogenetic protein-4 gene. J Orthop Surg Res 10:86
Gao, Xueqin; Usas, Arvydas; Proto, Jonathan D et al. (2014) Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects. FASEB J 28:3792-809
Gao, Xueqin; Usas, Arvydas; Tang, Ying et al. (2014) A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP. Biomaterials 35:6859-70
Li, Hongshuai; Johnson, Noah Ray; Usas, Arvydas et al. (2013) Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells. Stem Cells Transl Med 2:667-77
Gao, Xueqin; Usas, Arvydas; Lu, Aiping et al. (2013) BMP2 is superior to BMP4 for promoting human muscle-derived stem cell-mediated bone regeneration in a critical-sized calvarial defect model. Cell Transplant 22:2393-408
Zheng, Bo; Li, Guangheng; Chen, William C W et al. (2013) Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level. J Orthop Res 31:1089-95
Zheng, Bo; Chen, Chien-Wen; Li, Guangheng et al. (2012) Isolation of myogenic stem cells from cultures of cryopreserved human skeletal muscle. Cell Transplant 21:1087-93
Meszaros, Laura B; Usas, Arvydas; Cooper, Gregory M et al. (2012) Effect of host sex and sex hormones on muscle-derived stem cell-mediated bone formation and defect healing. Tissue Eng Part A 18:1751-9

Showing the most recent 10 out of 47 publications